StockData
NervGen Pharma Corp. logo

NervGen Pharma Corp. (NGEN) stock

NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.96+0.14 (+7.69%)

Close on Nov 17, 2026Market cap $156.11MP/E –Yield –

NervGen Pharma cash

Cash and short-term investments held at the end of each period.

NervGen Pharma's cash was C$22.07M at Dec 31, 2025. For fiscal 2025 it was C$22.07M, up 27.8% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025C$22.07M+27.8%
FY2024Dec 31, 2024C$17.27M+48.1%
FY2023Jan 1, 2024C$11.66M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2025Dec 31, 2025C$22.07M–
Q4 FY2024Dec 31, 2024C$17.27M–
Q4 FY2023Jan 1, 2024C$11.66M–

More NervGen Pharma figures

See a number that looks wrong?